How many drugs treat Congestive heart failure?

Drug Landscape tracks 5 marketed treatments for Congestive heart failure (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/congestive-heart-failure.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Congestive heart failure — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Congestive heart failure (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Congestive heart failure, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Vasotec	ENALAPRILAT	Biovail Labs Intl	enalaprilat	Angiotensin-converting enzyme	1988-01-01
Vasotec	enalapril	Merck & Co.	ACE inhibitor	Angiotensin-converting enzyme, Angiotensin-converting enzyme	1985-12-24
Vasotec	ENALAPRIL MALEATE	Azurity	Angiotensin Converting Enzyme Inhibitor	Angiotensin-converting enzyme	1985-01-01
Acylanid	ACETYLDIGITOXIN	Novartis	acetyldigitoxin	Sodium/potassium-transporting ATPase	1975-01-01
Simdax	Simdax	Yooyoung Pharmaceutical Co., Ltd.		ATP-sensitive inward rectifier potassium channel 8, ATP-sensitive inward rectifier potassium channel 11, Troponin C, slow skeletal and cardiac muscles

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 4 drugs in Congestive heart failure
Azurity · 1 drug in Congestive heart failure
Biovail Labs Intl · 1 drug in Congestive heart failure
Merck & Co. · 1 drug in Congestive heart failure
Novartis · 1 drug in Congestive heart failure
Yooyoung Pharmaceutical Co., Ltd. · 1 drug in Congestive heart failure

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Congestive heart failure:

Cite this brief

Drug Landscape (2026). Congestive heart failure — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/congestive-heart-failure. Accessed 2026-06-10.

Congestive heart failure full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing